Verisign (VRSN) Q3 2025 Financial Results Summary

0
1

Verisign (VRSN) Q3 2025 Financial Results Summary

Verisign, Inc. (NASDAQ: VRSN) released its financial results for the third quarter of 2025 on October 23, 2025. The report presents a comprehensive overview of the company’s financial and operational performance during the quarter.

Financial Highlights

  • Revenue: $419 million, up 7.3% from Q3 2024’s $390.6 million.
  • Operating Income: $284 million, an increase from $269 million in Q3 2024.
  • Net Income: $213 million, compared to $201 million in Q3 2024.
  • Diluted Earnings Per Share (EPS): $2.27, up from $2.07 in Q3 2024.

Additional Financial Metrics

  • Cash, Cash Equivalents and Marketable Securities: Ended Q3 2025 with $618 million, an increase of $18 million from the end of 2024.
  • Cash Flow from Operations: $308 million, compared to $253 million in Q3 2024, reflecting a year-over-year increase.
  • Deferred Revenues: As of September 30, 2025, totaled $1.38 billion, up $80 million from year-end 2024.
  • Share Repurchase: 0.8 million shares repurchased during Q3 2025 for $215 million; $1.33 billion remains for future repurchases.
  • Dividend Declared: On October 21, 2025, the Board approved a cash dividend of $0.77 per share, payable on November 25, 2025, to stockholders of record as of November 18, 2025.

Business Highlights

  • Domain Name Registrations:
  • Ended Q3 2025 with 171.9 million .com and .net domain name registrations, reflecting a 1.4% increase compared to Q3 2024.
  • Achieved a net increase of 1.45 million domain names during Q3 2025.
  • New Registrations: Processed 10.6 million new .com and .net registrations, an increase from 9.3 million in Q3 2024.
  • Renewal Rate: The renewal rate for .com and .net domains for Q2 2025 was 75.5%, an improvement from 72.7% in Q2 2024.

Outlook

Jim Bidzos, the Executive Chairman, President, and CEO, emphasized the company’s ability to deliver growth in the domain name base and strong financial performance while continuing to return value to shareholders through dividends and share repurchases.


This summary encapsulates Verisign’s Q3 2025 performance, demonstrating balanced growth across financial and operational fronts while maintaining a commitment to shareholder value through dividends and stock repurchase strategies.

Here are the extracted tables from the press release:

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In millions, except per share data)

Three Months Ended September 30, Nine Months Ended September 30,
2025 2024 2025 2024
Revenues $419.1 $390.6 $1,231.3 $1,162.0
Costs and expenses:
Cost of revenues 48.8 46.8 147.3 143.0
Research and development 25.4 23.2 77.1 71.8
Selling, general and administrative 60.6 51.3 170.7 152.8
Total costs and expenses 134.8 121.3 395.1 367.6
Operating income 284.3 269.3 836.2 794.4
Interest expense -18.9 -18.9 -58.1 -56.5
Non-operating income, net 6.3 10.5 19.3 35.9
Income before income taxes 271.7 260.9 797.4 773.8
Income tax expense -58.9 -59.6 -177.9 -179.6
Net income 212.8 201.3 619.5 594.2
Other comprehensive income (loss) 0.1 0.4 -0.2 0.2
Comprehensive income $212.9 $201.7 $619.3 $594.4
Earnings per share:
Basic $2.28 $2.07 $6.60 $6.00
Diluted $2.27 $2.07 $6.58 $6.00
Shares used to compute earnings per share
Basic 93.3 97.3 93.9 99.0
Diluted 93.6 97.3 94.1 99.1

CONDENSED CONSOLIDATED BALANCE SHEETS

(In millions, except par value)

September 30, 2025 December 31, 2024
ASSETS
Current assets:
Cash and cash equivalents $235.4 $206.7
Marketable securities 382.3 393.2
Other current assets 70.7 63.9
Total current assets 688.4 663.8
Property and equipment, net 218.6 224.5
Goodwill 52.5 52.5
Deferred tax assets 267.3 281.3
Deposits to acquire intangible assets 145.0 145.0
Other long-term assets 31.9 39.4
Total long-term assets 715.3 742.7
Total assets $1,403.7 $1,406.5
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accounts payable and accrued liabilities $271.0 $257.8
Deferred revenues 1,036.1 973.5
Current senior notes 299.8
Total current liabilities 1,307.1 1,531.1
Long-term deferred revenues 348.2 330.7
Long-term senior notes 1,787.6 1,492.5
Long-term tax and other liabilities 11.3 10.1
Total long-term liabilities 2,147.1 1,833.3
Total liabilities 3,454.2 3,364.4
Commitments and contingencies
Stockholders’ deficit:
Preferred stock—par value $.001 per share; Authorized shares: 5.0; Issued and outstanding shares: none
Common stock and additional paid-in capital—par value $.001 per share; Authorized shares: 1,000; Issued shares: 9,933.4 10,645.3
Outstanding shares: 92.9 at September 30, 2025 and 95.0 at December 31, 2024
Accumulated deficit -11,981.2 -12,600.7
Accumulated other comprehensive loss -2.7 -2.5
Total stockholders’ deficit -2,050.5 -1,957.9
Total liabilities and stockholders’ deficit $1,403.7 $1,406.5